ATLAS / Macro Radar / Reporting / RPRX

Royalty Pharma plc (RPRX) reporting calendar

Royalty Pharma plc files periodic reports with the SEC as RPRX on Nasdaq. Atlas tracks 24 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
1 Aug 2026 – 11 Aug 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
6 May 2026
Reports on record
24

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 37 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 20266 May 202636 days0001802768-26-000009
10-K31 Dec 202511 Feb 202642 days0001802768-26-000003
10-Q30 Sep 20255 Nov 202536 days0001802768-25-000114
10-Q30 Jun 20256 Aug 202537 days0001802768-25-000095
10-Q31 Mar 20258 May 202538 days0001802768-25-000027
10-K31 Dec 202412 Feb 202543 days0001802768-25-000010
10-Q30 Sep 20246 Nov 202437 days0001802768-24-000058
10-Q30 Jun 20248 Aug 202439 days0001802768-24-000045
10-Q31 Mar 20249 May 202439 days0001802768-24-000021
10-K31 Dec 202315 Feb 202446 days0001802768-24-000012
10-Q30 Sep 20238 Nov 202339 days0001802768-23-000029
10-Q30 Jun 20238 Aug 202339 days0001802768-23-000023
10-Q31 Mar 20239 May 202339 days0001802768-23-000015
10-K31 Dec 202215 Feb 202346 days0001802768-23-000007
10-Q30 Sep 20228 Nov 202239 days0001802768-22-000045
10-Q30 Jun 20224 Aug 202235 days0001802768-22-000035
10-Q31 Mar 20225 May 202235 days0001802768-22-000020
10-K31 Dec 202115 Feb 202246 days0001802768-22-000011
10-Q30 Sep 202110 Nov 202141 days0001802768-21-000040
10-Q30 Jun 202111 Aug 202142 days0001802768-21-000026
10-Q31 Mar 202111 May 202141 days0001802768-21-000016
10-K31 Dec 202024 Feb 202155 days0001802768-21-000006
10-Q30 Sep 202012 Nov 202043 days0001802768-20-000010
10-Q30 Jun 202012 Aug 202043 days0001802768-20-000005

Source: SEC EDGAR company submissions for CIK 0001802768. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.